ATE336230T1 - Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung - Google Patents
Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellungInfo
- Publication number
- ATE336230T1 ATE336230T1 AT04003906T AT04003906T ATE336230T1 AT E336230 T1 ATE336230 T1 AT E336230T1 AT 04003906 T AT04003906 T AT 04003906T AT 04003906 T AT04003906 T AT 04003906T AT E336230 T1 ATE336230 T1 AT E336230T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- production
- oral pharmaceutical
- composition
- bet
- Prior art date
Links
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
- 229940124339 anthelmintic agent Drugs 0.000 abstract 1
- 239000000921 anthelmintic agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04003906A EP1566173B1 (de) | 2004-02-20 | 2004-02-20 | Orale pharmazeutische Zusammensetzung und Verfahren zu ihrer Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE336230T1 true ATE336230T1 (de) | 2006-09-15 |
Family
ID=34707350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04003906T ATE336230T1 (de) | 2004-02-20 | 2004-02-20 | Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7767228B2 (de) |
| EP (2) | EP1566173B1 (de) |
| JP (1) | JP4800225B2 (de) |
| AT (1) | ATE336230T1 (de) |
| AU (1) | AU2005215108B2 (de) |
| BR (1) | BRPI0507848A (de) |
| CA (1) | CA2554640C (de) |
| DE (1) | DE602004001969T2 (de) |
| DK (1) | DK1566173T3 (de) |
| ES (1) | ES2271714T3 (de) |
| NO (1) | NO20064240L (de) |
| PT (1) | PT1566173E (de) |
| RU (1) | RU2342936C2 (de) |
| SI (1) | SI1566173T1 (de) |
| WO (1) | WO2005079759A2 (de) |
| ZA (1) | ZA200606554B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1883396B1 (de) * | 2005-05-18 | 2013-07-03 | DA Volterra | Abgabe von adsorbentien im colon |
| US8048413B2 (en) * | 2006-05-17 | 2011-11-01 | Helene Huguet | Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| UY31410A1 (es) * | 2007-10-30 | 2009-05-29 | Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado | |
| JP2010106007A (ja) * | 2008-08-14 | 2010-05-13 | Sony Corp | 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート |
| UA105648C2 (uk) * | 2008-12-05 | 2014-06-10 | Баєр Інтеллекчуел Проперті Гмбх | Екструдати з голчатими активними речовинами |
| HU231017B1 (hu) | 2012-05-08 | 2019-11-28 | LAVET Gyógyszeripari Kft. | Praziquantel tartalmú ízfedett formulációk |
| RU2514056C2 (ru) * | 2012-08-21 | 2014-04-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации | Способ инкапсуляции фенбендазола |
| JP6472341B2 (ja) * | 2015-06-26 | 2019-02-20 | 株式会社トーヨー技術研究所 | 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法 |
| AU2021335500A1 (en) | 2020-09-04 | 2023-05-04 | Elanco Us Inc. | Palatable formulations |
| WO2023032048A1 (ja) * | 2021-08-31 | 2023-03-09 | 株式会社トーヨー技術研究所 | 水棲動物用経口投与薬剤 |
| WO2023032049A1 (ja) * | 2021-08-31 | 2023-03-09 | 株式会社トーヨー技術研究所 | 水棲動物用経口投与薬剤 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1879601A (en) * | 1926-03-13 | 1932-09-27 | Merck & Co Inc | Iodine composition |
| BE634024A (de) * | 1962-06-25 | |||
| US3709833A (en) * | 1970-08-21 | 1973-01-09 | Owens Illinois Inc | Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides |
| US4581232A (en) * | 1983-07-20 | 1986-04-08 | Warner-Lambert Company | Magnesium trisilicate suitable for preparation of medicament adsorbates |
| SU1465052A1 (ru) * | 1985-06-10 | 1989-03-15 | Институт Зоологии Ан Казсср | Способ профилактики и лечени гельминтозов животных |
| US5013716A (en) * | 1988-10-28 | 1991-05-07 | Warner-Lambert Company | Unpleasant taste masking compositions and methods for preparing same |
| RU2034549C1 (ru) * | 1990-05-29 | 1995-05-10 | Научно-производственное малое предприятие "Аксис" | Антгельминтное средство для лечения нематодозов овец |
| JPH05238930A (ja) * | 1992-02-28 | 1993-09-17 | Eisai Co Ltd | 持続性薬剤 |
| RU2092155C1 (ru) * | 1993-06-22 | 1997-10-10 | Валентина Ивановна Ходак | Способ получения твердого лекарственного препарата для перорального введения |
| IL116674A (en) * | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
| US5585115A (en) * | 1995-01-09 | 1996-12-17 | Edward H. Mendell Co., Inc. | Pharmaceutical excipient having improved compressability |
| US5827497A (en) * | 1996-08-14 | 1998-10-27 | Mayo Foundation For Medical Education And Research | Charcoal-radionuclide agents for measurement of gastrointestinal transit |
| CA2261787C (en) * | 1997-05-30 | 2006-11-14 | Laboratorios Phoenix U.S.A., Inc. | Multi-layered osmotic device |
| DE19726412A1 (de) * | 1997-06-21 | 1998-12-24 | Merck Patent Gmbh | Implantatmaterial mit einer Träger-Wirkstoff-Kombination |
| US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| JP3834732B2 (ja) * | 1998-08-05 | 2006-10-18 | 株式会社ロッテ | チューインガム |
| US6555139B2 (en) * | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
| US6491949B2 (en) * | 2000-01-14 | 2002-12-10 | Osmotica Corp. | Osmotic device within an osmotic device |
| US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
| EP1362583A1 (de) * | 2002-05-15 | 2003-11-19 | CUM Taste Masking AG | Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung |
| US7001889B2 (en) * | 2002-06-21 | 2006-02-21 | Merial Limited | Anthelmintic oral homogeneous veterinary pastes |
| EP2314171B1 (de) * | 2002-08-13 | 2019-11-13 | Intervet International BV | Zusammensetzungen und verabreichungsprozess für einen zusatzstoff |
| AU2003280670A1 (en) * | 2002-10-31 | 2004-05-25 | Matsushita Electric Industrial Co., Ltd. | Porous electrode and electrochemical device using the same |
-
2004
- 2004-02-20 SI SI200430070T patent/SI1566173T1/sl unknown
- 2004-02-20 DK DK04003906T patent/DK1566173T3/da active
- 2004-02-20 ES ES04003906T patent/ES2271714T3/es not_active Expired - Lifetime
- 2004-02-20 PT PT04003906T patent/PT1566173E/pt unknown
- 2004-02-20 EP EP04003906A patent/EP1566173B1/de not_active Expired - Lifetime
- 2004-02-20 AT AT04003906T patent/ATE336230T1/de active
- 2004-02-20 DE DE602004001969T patent/DE602004001969T2/de not_active Expired - Lifetime
- 2004-03-05 US US10/794,310 patent/US7767228B2/en not_active Expired - Fee Related
-
2005
- 2005-02-09 RU RU2006133543/15A patent/RU2342936C2/ru active
- 2005-02-09 BR BRPI0507848-2A patent/BRPI0507848A/pt not_active IP Right Cessation
- 2005-02-09 ZA ZA200606554A patent/ZA200606554B/xx unknown
- 2005-02-09 JP JP2006553492A patent/JP4800225B2/ja not_active Expired - Fee Related
- 2005-02-09 AU AU2005215108A patent/AU2005215108B2/en not_active Ceased
- 2005-02-09 WO PCT/EP2005/001297 patent/WO2005079759A2/en not_active Ceased
- 2005-02-09 EP EP05701388A patent/EP1715850A2/de not_active Withdrawn
- 2005-02-09 CA CA2554640A patent/CA2554640C/en not_active Expired - Fee Related
-
2006
- 2006-09-19 NO NO20064240A patent/NO20064240L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005215108A1 (en) | 2005-09-01 |
| EP1566173B1 (de) | 2006-08-16 |
| RU2342936C2 (ru) | 2009-01-10 |
| DE602004001969D1 (de) | 2006-09-28 |
| US7767228B2 (en) | 2010-08-03 |
| ZA200606554B (en) | 2008-05-28 |
| AU2005215108B2 (en) | 2010-10-07 |
| EP1566173A1 (de) | 2005-08-24 |
| WO2005079759A3 (en) | 2006-06-15 |
| ES2271714T3 (es) | 2007-04-16 |
| NO20064240L (no) | 2006-11-20 |
| SI1566173T1 (sl) | 2006-12-31 |
| US20050186272A1 (en) | 2005-08-25 |
| RU2006133543A (ru) | 2008-04-10 |
| BRPI0507848A (pt) | 2007-07-10 |
| PT1566173E (pt) | 2006-12-29 |
| DE602004001969T2 (de) | 2007-03-15 |
| DK1566173T3 (da) | 2006-12-27 |
| JP2007523108A (ja) | 2007-08-16 |
| EP1715850A2 (de) | 2006-11-02 |
| JP4800225B2 (ja) | 2011-10-26 |
| CA2554640A1 (en) | 2005-09-01 |
| WO2005079759A2 (en) | 2005-09-01 |
| CA2554640C (en) | 2011-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60100186D1 (de) | Orale pharmazeutische formulierungen von benzimidazolderivaten und verfahren zu ihrer herstellung | |
| WO2007098128A3 (en) | Phenylephrine-containing liquid formulations | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| ATE252562T1 (de) | Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE514694T1 (de) | 2-amino-7,8-dihydro-6h-pyrido(4,3-d)pyrimidin-5 one, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| DE60215851D1 (de) | N-adamantylmethyl-derivate und zwischenprodukte als pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung | |
| PE20050484A1 (es) | Composicion farmaceutica de liberacion sostenida | |
| ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| ATE336230T1 (de) | Orale pharmazeutische zusammensetzung und verfahren zu ihrer herstellung | |
| CY1112960T1 (el) | Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων | |
| EP1651651A4 (de) | Cucurbiturilderivate enthaltende nanopartikel, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
| AU2003230189A1 (en) | Oral controlled release pharmaceutical composition containing metaxalone as active agent | |
| DE602007005601D1 (de) | Pharmazeutische zusammensetzungen, enthaltend valatograst, und verfahren zu deren herstellung | |
| ATE471930T1 (de) | 3-aminocarbazolverbindungen, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
| ATE374172T1 (de) | Hexensäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| DK1730144T3 (da) | Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser | |
| MX2008001560A (es) | Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| ATE528301T1 (de) | Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen | |
| ATE503749T1 (de) | Buttersäurederivate, verfahren zu deren herstellung, pharmazeutische zusammensetzungen, die diese enthalten, und therapeutische anwendungen davon | |
| ATE358470T1 (de) | Pharmazeutische zusammensetzung mit kontrollierter freisetzung und verfahren zu ihrer herstellung | |
| DE602004003719D1 (de) | 9-aminopodophyllotoxinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese derivate enthalten | |
| ATE474558T1 (de) | Pharmazeutische formulierungen mit irbesartan | |
| ATE248171T1 (de) | Isoindoloindolon-derivate, verfahren zu ihrer herstellung und die enthaltende pharmazeutische zusammensetzungen | |
| ATE374177T1 (de) | Cyclohexyl(alkyl)-propanolamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE409463T1 (de) | Oral dispergierbare pharmazeutische zusammensetzung und verfahren zu ihrer herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1566173 Country of ref document: EP |